| Table of Contents | Words: Alphabetical - Frequency - Inverse - Length - Statistics | Help | IntraText Library | ||
| Alphabetical [« »] leukemia 2 leukocytosis 1 level 229 levels 148 leverage 2 liaison 2 lib 1 | Frequency [« »] 149 behaviors 149 perform 148 feelings 148 levels 148 physician 146 how 144 effects | A. Rossi Mori (CNR-ITB); EuloTech Nursing terminology IntraText IntraText - Concordances levels |
Source,TTY
1 NAN94PT| improved resulting in higher levels of integration in response 2 NIC96AC| supplements to reduce phosphate levels, as appropriate [C0508340] [ 3 NIC96AC| reduce serum ionized calcium levels (e.g., phosphate, sodium 4 NIC96AC| patient to tolerate increased levels of stress, as appropriate [ 5 NIC96AC| activities to accommodate energy levels [C0508976] [U000903]~----~ 6 NIC96AC| bicarbonate, decreased chloride levels and decreased serum potassium; 7 NIC96AC| evaluating toxic and therapeutic levels of drugs [C0509622] [U001557]~----~ 8 NIC96AC| opioids, to maintain serum levels [C0509636] [U001571]~----~ 9 NIC96AC| U001731]~----~Decrease noise levels by avoiding paging systems 10 NIC96AC| hemoglobin and hematocrit levels [C0509956] [U001892]~----~ 11 NIC96AC| scale of upper and lower levels related to expected outcomes 12 NIC96AC| creatinine, serum Na, K, and PO4 levels) pretreatment [C0510495] [ 13 NIC96AC| serum, CK, LDH, and AST levels, as appropriate [C0510497] [ 14 NIC96AC| dental floss, if platelet levels are above 50,000/mm3 [C0510648] [ 15 NIC96AC| self-monitoring of blood glucose levels [C0510856] [U002804]~----~ 16 NIC96AC| programmed increases in levels of activities [C0511130] [ 17 NIC96AC| conjunction with the PaCO2and HCO3 levels to determine whether the 18 NIC96AC| U003699]~----~Identify scale levels that are defined by behavioral 19 NIC96AC| moderate or large urine ketone levels to the health professional [ 20 NIC96AC| cholesterol and blood sugar levels, and urinalysis, as appropriate [ 21 NIC96AC| Monitor ABG and electrolyte levels, as available [C0512938] [ 22 NIC96AC| U004918]~----~Monitor ABG levels for decreasing pH level, 23 NIC96AC| U004919]~----~Monitor ABG levels for increased pH level [ 24 NIC96AC| and betahydroxybutyrate levels, as available [C0512941] [ 25 NIC96AC| hemaglobin, and hematocrit levels [C0512969] [U004950]~----~ 26 NIC96AC| Monitor antiepileptic drug levels, as appropriate [C0512990] [ 27 NIC96AC| Monitor blood glucose levels, as indicated [C0512998] [ 28 NIC96AC| total protein, and albumin levels [C0512943] [U004923]~----~ 29 NIC96AC| U004923]~----~Monitor calcium levels closely in the patient receiving 30 NIC96AC| increasing serum potassium levels (e.g., renal failure, excessive 31 NIC96AC| closely the serum potassium levels of patients taking digitalis 32 NIC96AC| e.g., PaO2and hemoglobin levels and cardiac output), if 33 NIC96AC| PaCO2, SaO2, and hemoglobin levels and cardiac output), if 34 NIC96AC| PaO2, SaO2, and hemoglobin levels and cardiac output), if 35 NIC96AC| PaO2, SaO2, and hemoglobin levels, and cardiac output), if 36 NIC96AC| consumption (e.g., SvO2 and avDO2 levels), if available [C0513076] [ 37 NIC96AC| decreasing serum potassium levels (e.g., administration of 38 NIC96AC| CO2, Qsp/Qt, and A-aDO2 levels and patient's subjective 39 NIC96AC| to abnormal K, Ca, and Mg levels [C0512947] [U004928]~----~ 40 NIC96AC| Monitor electrolyte levels [C0513091] [U005077]~----~ 41 NIC96AC| electrolyte, BUN, and creatinine levels daily [C0513092] [U005078]~----~ 42 NIC96AC| enzyme, and blood sugar levels [C0513093] [U005079]~----~ 43 NIC96AC| Monitor fluid and electrolyte levels, liver function tests, blood 44 NIC96AC| and arterial blood gas levels [C0513121] [U005108]~----~ 45 NIC96AC| abnormal serum electrolyte levels, as available [C0513157] [ 46 NIC96AC| causes of increasing calcium levels (e.g., indications of severe 47 NIC96AC| Monitor for decreasing levels of consciousness [C0513218] [ 48 NIC96AC| Monitor for decreasing levels of magnesium resulting from 49 NIC96AC| toxicity (e.g., report serum levels above therapeutic range, 50 NIC96AC| e.g., elevated BUN and Cr levels), as appropriate [C0513244] [ 51 NIC96AC| serum and urine phosphate levels, serum and urine calcium 52 NIC96AC| urine calcium and magnesium levels), as appropriate [C0513245] [ 53 NIC96AC| calcium, and magnesium levels), as appropriate [C0513249] [ 54 NIC96AC| increased BUN and creatinine levels, myoglobinemia, and decreased 55 NIC96AC| decreasing serum potassium levels (e.g., diarrhea, fistulas, 56 NIC96AC| hemoglobin and hematocrit levels, if appropriate [C0513468] [ 57 NIC96AC| Monitor hemoglobin/hematocrit levels [C0513468] [U005472]~----~ 58 NIC96AC| decreasing serum potassium levels (e.g., metabolic alkalosis; 59 NIC96AC| osmolality, sodium, and potassium levels [C0513494] [U005500]~----~ 60 NIC96AC| especially Hgb and Hct levels, clotting profile, ABG and 61 NIC96AC| profile, ABG and electrolyte levels, cultures, and chemistry 62 NIC96AC| U005516]~----~Monitor levels of self-esteem over time, 63 NIC96AC| lymphocyte and electrolyte levels [C0513518] [U005524]~----~ 64 NIC96AC| risk for increasing calcium levels due to bone resorption ( 65 NIC96AC| oxygen status (SaO2 and SvO2 levels) and hemodynamic status ( 66 NIC96AC| rhythm and rate, and comfort levels [C0513611] [U005622]~----~ 67 NIC96AC| vital signs and electrolyte levels), as needed [C0513664] [ 68 NIC96AC| Monitor potassium levels after diuresis [C0513670] [ 69 NIC96AC| decreasing serum potassium levels (e.g., diuretics, diuresis, 70 NIC96AC| increasing serum phosphate levels [C0513699] [U005713]~----~ 71 NIC96AC| function (e.g., BUN and CR levels), if appropriate [C0513700] [ 72 NIC96AC| function (e.g., BUN and Cr levels), if appropriate [C0513700] [ 73 NIC96AC| EKG, and serum potassium levels during replacement, as appropriate [ 74 NIC96AC| respiratory status: ABG Levels, pulse oximetry, depth, 75 NIC96AC| pCO2, pH, and bicarbonate levels [C0513713] [U005731]~----~ 76 NIC96AC| albumin and total protein levels, as indicated [C0513731] [ 77 NIC96AC| albumin and total protein levels [C0513731] [U005749]~----~ 78 NIC96AC| albumin and total protein levels, if available [C0513732] [ 79 NIC96AC| lymphocyte, and electrolyte levels [C0513733] [U005752]~----~ 80 NIC96AC| electrolyte, and glucose levels and chemistry profile [C0513734] [ 81 NIC96AC| serum and urine osmolality levels [C0513736] [U005755]~----~ 82 NIC96AC| Monitor serum bilirubin levels, per protocol or practitioner 83 NIC96AC| Monitor serum electrolyte levels [C0513738] [U005757]~----~ 84 NIC96AC| glucose and treat abnormal levels, as appropriate [C0513739] [ 85 NIC96AC| end-tidal CO2, Qsp/Qt, A-aDO2 levels [C0513787] [U005808]~----~ 86 NIC96AC| Monitor trends in magnesium levels, as available [C0513813] [ 87 NIC96AC| Monitor trends in serum levels of calcium (e.g., ionized 88 NIC96AC| urine glucose and protein levels [C0513820] [U005844]~----~ 89 NIC96AC| Note hemoglobin/hematocrit levels before and after blood loss, 90 NIC96AC| the PaO2, SaO2, and Hgb levels to determine the adequacy 91 NIC96AC| Obtain arterial blood gas levels, if appropriate [C0514005] [ 92 NIC96AC| Obtain cord blood gas levels at the time of delivery 93 NIC96AC| analysis of altered sodium levels (e.g., serum and urine sodium, 94 NIC96AC| altered fluid or electrolyte levels (e.g., hematocrit, BUN, 95 NIC96AC| protein, sodium, and potassium levels), as appropriate [C0514049] [ 96 NIC96AC| e.g., ABG, urine, and serum levels), as appropriate [C0514055] [ 97 NIC96AC| analysis of electrolyte levels (e.g., AGB, urine, and serum 98 NIC96AC| e.g., AGB, urine, and serum levels), as appropriate [C0514056] [ 99 NIC96AC| and associated electrolyte levels (e.g., ABG, urine, and serum 100 NIC96AC| e.g., ABG, urine, and serum levels), as appropriate [C0514070] [ 101 NIC96AC| and associated electrolyte levels (e.g., ABG, urine, and serum 102 NIC96AC| e.g., ABG, urine, and serum levels), as appropriate [C0514072] [ 103 NIC96AC| laboratory analysis of potassium levels and associated electrolyte 104 NIC96AC| e.g., ABG, urine, and serum levels), as appropriate [C0514073] [ 105 NIC96AC| Order serum bilirubin levels, as appropriate, per protocol 106 NIC96AC| Recognize that trough drug levels are useful for demonstrating 107 NIC96AC| exercise when blood glucose levels are >250 mg/dl, especially 108 NIC96AC| hemoglobin or hematocrit levels, Rh status, urine dipstick, 109 NIC96AC| U008420]~----~Use peak drug levels when testing for toxicity [ 110 NIC96PT| resulting from serum HCO3 levels lower than desired~Acid-Base 111 NIC96PT| resulting from serum HCO3 levels higher than desired~Acid-Base 112 NIC96PT| resulting from serum pCO2 levels higher than desired~Acid-Base 113 NIC96PT| resulting from serum pCO2 levels lower than desired~Acid-Base 114 NIC96PT| undesired serum electrolyte levels~Electrolyte Management: 115 NIC96PT| resulting from serum calcium levels higher than desired~Electrolyte 116 NIC96PT| resulting from serum potassium levels higher than desired~Electrolyte 117 NIC96PT| resulting from serum magnesium levels higher than desired~Electrolyte 118 NIC96PT| resulting from serum sodium levels higher than desired~Electrolyte 119 NIC96PT| resulting from serum phosphate levels higher than desired~Electrolyte 120 NIC96PT| resulting from serum calcium levels lower than desired~Electrolyte 121 NIC96PT| resulting from serum potassium levels lower than desired~Electrolyte 122 NIC96PT| resulting from serum magnesium levels lower than desired~Electrolyte 123 NIC96PT| resulting from serum sodium levels lower than desired~Electrolyte 124 NIC96PT| resulting from serum phosphate levels lower than desired~Electrolyte 125 NIC96PT| abnormal or undesired fluid levels~Fluid Monitoring [C0150237] [ 126 NIC96PT| fluid and/or electrolyte levels~Foot Care [C0150240] [1660]~ 127 NIC96PT| above normal blood glucose levels~Hypervolemia Management [ 128 NIC96PT| below normal blood glucose levels~Hypothermia Treatment [C0150255] [ 129 NIC96PT| oxygen and carbon dioxide levels and acid-base balance~Phlebotomy: 130 NIC96PT| therapy to reduce bilirubin levels in newborn infants~Physical 131 NIC96SA| of increasing magnesium levels [C0513200] [U005190]~----~ 132 NIC96SA| Monitor for decreasing levels of phosphate resulting from 133 NIC96SA| Monitor for decreasing levels of serum ionized calcium [ 134 NIC96SA| for decreasing phosphate levels resulting from extracellular 135 NIC96SA| for decreasing phosphate levels resulting from renal loss [ 136 NOC97ID| 120310]~----~Complement levels WNL [C0517588] [070121]~----~ 137 NOC97ID| 070121]~----~Complement levels WNL [C0517588] [070218]~----~ 138 NOC97ID| Displays increasing levels of autonomy [C0517188] [ 139 NOC97ID| Elimination of harmful noise levels [C0518419] [191020]~----~ 140 NOC97IX| 110107]~----~Complement levels within normal limits [C0517588] [ 141 NOC97IX| 070121]~----~Complement levels within normal limits [C0517588] [ 142 PCDS97GO| or return to, appropriate levels. [C0548629] [GOL_09000.04]~----~ 143 PCDS97GO| 00]~----~Medication blood levels will be maintained at therapeutic 144 PCDS97GO| maintained at therapeutic levels. [C0548619] [GOL_08000.01]~----~ 145 PCDS97GO| 17200.00]~----~Serum lipid levels will improve or stabilize 146 PCDS97OR| Assess current patterns and levels of mobility and activity. [ 147 PCDS97OR| wall chart for cyclosporin levels prior to administration 148 PCDS97OR| 09000.04]~----~Monitor blood levels of medication to maintain